In addition, Noggin has been found to be able to inhibit angiogenesis in lung cancer models [17], suggesting that its loss or downregulation in lung cancer cells may contribute to angiogenic switch that occurs in tumor progression. This evidence concerns the gene NOG and lung carcinoma.